MANILA, Philippines — The Health Technology Assessment Council (HTAC) is doing an ethics and cost-effectiveness review for the procured Sinovac vaccines in March even as the donated China-made vaccine doses were already rolled out to health workers, Health Chief Francisco Duque III said Tuesday.
“The HTAC is doing evaluation already of Sinovac because we will also procure. In fact, what we expect is about maybe third week of March, we will be able to see the procured 1 million doses of Sinovac,” Duque said in an interview with ABS-CBN News Channel, reacting to criticisms that the donated Sinovac shots should undergo HTAC evaluation, which seeks to assess the cost, ethics, and commun…
Keep on reading: Despite rollout, HTAC evaluation on Sinovac ongoing — Duque